[HTML][HTML] Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang, Z Deng, Y Ma, X Yan… - Journal of …, 2023 - Springer
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Y Cao, K Cheng, M Yang, Z Deng… - Journal of …, 2023 - search.ebscohost.com
Background: Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Y Cao, K Cheng, M Yang, Z Deng, Y Ma… - Journal of …, 2023 - europepmc.org
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
[HTML][HTML] Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang… - Journal of …, 2023 - jnanobiotechnology.biomedcentral …
Inflammatory bowel disease (IBD) is a chronic nonspecific disease with unknown etiology.
Currently, the anti-inflammatory therapeutic approaches have achieved a certain extent of …
Currently, the anti-inflammatory therapeutic approaches have achieved a certain extent of …
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang, Z Deng… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang, Z Deng, Y Ma… - Journal of …, 2023 - search.proquest.com
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease.
Y Cao, K Cheng, M Yang, Z Deng, Y Ma, X Yan… - 2023 - cabidigitallibrary.org
Background: Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
[HTML][HTML] Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang, Z Deng, Y Ma… - Journal of …, 2023 - ncbi.nlm.nih.gov
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
[PDF][PDF] Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease
Y Cao, K Cheng, M Yang, Z Deng, Y Ma, X Yan… - 2023 - jnanobiotechnology.biomedcentral …
Background Inflammatory bowel disease (IBD) is a chronic nonspecific disease with
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …
unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a …